Results 161 to 170 of about 419,069 (401)

SF3A3 Drives Tumorigenesis in Endometrial Cancer by Enhancing c‐FOS Expression and Represents a Potential Therapeutic Target

Advanced Science, EarlyView.
The role of splicing factor 3A subunit 3 (SF3A3) in driving endometrial cancer (EC) progression and potential therapeutic interventions. SF3A3, a core component of the U2 small nuclear ribonucleoprotein (U2 snRNP), is upregulated in endometrial cancer (EC) and promotes tumor growth and cisplatin resistance. RNA‐binding protein immunoprecipitation (RIP)
Wei Yu, Yi Gu, Hengrui Zhang, Wunan Huang, Lei Sun, Liangjian Ma, Xiaolei Liang, Lexin Liu, Guiping Chen, Weihua Wang, Zhongkai Cao, Xue Li, Xiangjun Chen, Lidan Hu   +13 more
wiley   +1 more source

Maintenance of growth with aggressive hemodialysis therapy in children with chronic renal insufficiency † 1683 [PDF]

, 1997
Celia Rodd, Alexander Tom, Lynn McCauley, Pauline Espinosa, Lorraine Bell, Grace Yu, Joyce Yu, Atul Sharma   +7 more
openalex   +1 more source

Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.

American Society of Nephrology. Clinical Journal, 2017
Rupal Mehta, Xuan Cai, Alexander J. Hodakowski, J. Lee, M. Leonard, A. Ricardo, J. Chen, L. Hamm, J. Sondheimer, M. Dobre, V. David, Wei Yang, A. Go, J. Kusek, H. Feldman, M. Wolf, T. Isakova   +16 more
semanticscholar   +1 more source

Covalent Organic Frameworks‐Delivered Reuterin Drives Trained Immunity in Tumor‐Associated Macrophages to Enhance Melanoma Immunotherapy via Glycerophospholipid Metabolism

Advanced Science, EarlyView.
Covalent organic framework (COF)‐reuterin induces trained immunity in tumor‐associated macrophages, promoting the generation of nitric oxide and reactive oxygen species, thereby enhancing the antitumor immune response. Additionally, COF‐Reuterin directly kills tumor cells while simultaneously eradicating pathogenic intratumoural bacteria.
Jian‐Gang Zhang, Xiao‐Mei Zhang, Xi Wu, Cheng‐Kai Zhou, Zhen‐Zhen Liu, Xue‐Yue Luo, Liang Zhang, Wei Chen, Yong‐Jun Yang   +8 more
wiley   +1 more source

Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study. [PDF]

Kidney Med, 2023
Leidner AS, Cai X, Zelnick LR, Lee J, Bansal N, Pasch A, Kansal M, Chen J, Anderson AH, Sondheimer JH, Lash JP, Townsend RR, Go AS, Feldman HI, Shah SJ, Wolf M, Isakova T, Mehta RC, Chronic Renal Insufficiency Cohort (CRIC) study investigators.   +18 more
europepmc   +1 more source

Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease [PDF]

, 2016
Atkins, Bakris, Bianchi, Bomback, Brown, Brown, Brown, Brown, Bugbee, Christ, Finco, Grauer, Grauer, Horita, Jacob, Jenkins, Jepson, Jepson, Jonathan Elliott, King, King, Laverman, Lees, Lefebvre, LeVine, Linas, Littman, Maack, McAlister, Mizutani, Nabity, Nakamura, Pollock, Pressler, Ryan, Schjoedt, Schneider, Segev, Segev, Sent, Shelly L. Vaden, Singh, Syme, Tenhundfeld, Toblli, Vaden, Wehner   +46 more
core   +1 more source

Effects of acute and chronic dosing of NSAIDs in patients with renal insufficiency

, 1986
Robert D. Toto, Shirley Anderson, Debbie Brown–Cartwright, Juha P. Kokko, D. Craig Brater   +4 more
openalex   +1 more source

Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.

JAMA cardiology, 2016
MD RupalMehta, MS XuanCai, PhD JungwhaLee, Mdmhs JuliaJ.Scialla, Mdmas NishaBansal, MD JamesH.Sondheimer, MDMMScMSc JingChen, MD L.LeeHamm, Mdmphms AnaC.Ricardo, Mdmph SankarD.Navaneethan, MD RajatDeo, MD MahboobRahman, Mdmsce HaroldI.Feldman, MD AlanS.Go, MDMMSc TamaraIsakova, MDMMSc MylesWolf, Rahman FeldmanGoIsakovaWolf Scialla, Mehta, LeeBansalSondheimerChenHamm RicardoNavaneethanDeoRahmanGoIsakovaWolf Cai, Wolf Mehta   +19 more
semanticscholar   +1 more source

Nanoparticle Drug Delivery Systems for Atherosclerosis: Precision Targeting, Inflammatory Modulation, and Plaque Stabilization

Advanced Science, EarlyView.
This review first summarizes the complex pathogenesis of atherosclerosis and outlines the limitations of conventional therapies. It then explores innovative nanoparticle drug delivery system (NDDS) developments, detailing their precision targeting strategies, responsiveness to plaque‐specific stimuli, modulation of key pathological processes, and ...
Yunqi Zhang, Feifei Li, Libo Liu, Ziyu An, Hanzhong Luo, Huan Zhang, Rui Ma, Ruoxi Zhang, Qiong Dai, Mingduo Zhang, Jinfan Tian, Chaoyong Liu, Xiantao Song, Yunfeng Lu   +13 more
wiley   +1 more source

Risk for Chronic Kidney Disease Progression After Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort Study. [PDF]

Ann Intern Med, 2023
Muiru AN, Hsu JY, Zhang X, Appel LJ, Chen J, Cohen DL, Drawz PE, Freedman BI, Go AS, He J, Horwitz EJ, Hsu RK, Lash JP, Liu KD, McCoy IE, Porter A, Rao P, Ricardo AC, Rincon-Choles H, Sondheimer J, Taliercio J, Unruh M, Hsu CY, CRIC Study Investigators.   +23 more
europepmc   +1 more source